GlaxoSmithKline Pharmaceuticals

quarterly
yearly
ParticularsDec '21Mar '22Jun '22Sep '22Dec '22
Revenue815.92809.63745.10916.87802.30
Expenses653.90620.26612.00676.30601.38
EBITDA162.02189.37133.10240.57200.92
EBIT144.15174.02117.28224.21184.51
Profit Before Tax171.76207.85160.03262.15224.25
Net Profit150.351,219119.28193.42164.56
Financial Ratios
Operating Profit Margin19.86%23.39%17.86%26.24%25.04%
Net Profit Margin18.43%150.57%16.01%21.10%20.51%
Earning Per Share (Diluted)9.02-4.366.8611.4210.20
Dividends Per ShareNA30.00NANANA
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.8.0
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI